These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2935243)

  • 1. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries.
    Kemeny MM; Goldberg D; Beatty JD; Blayney D; Browning S; Doroshow J; Ganteaume L; Hill RL; Kokal WA; Riihimaki DU
    Cancer; 1986 Feb; 57(3):492-8. PubMed ID: 2935243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. A prospective randomized study.
    Kemeny MM; Goldberg DA; Browning S; Metter GE; Miner PJ; Terz JJ
    Cancer; 1985 Mar; 55(6):1265-70. PubMed ID: 3971296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver.
    Wagman LD; Kemeny MM; Leong L; Terz JJ; Hill LR; Beatty JD; Kokal WA; Riihimaki DU
    J Clin Oncol; 1990 Nov; 8(11):1885-93. PubMed ID: 2146370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial.
    Safi F; Bittner R; Roscher R; Schuhmacher K; Gaus W; Beger GH
    Cancer; 1989 Jul; 64(2):379-87. PubMed ID: 2525415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.
    Chang AE; Schneider PD; Sugarbaker PH; Simpson C; Culnane M; Steinberg SM
    Ann Surg; 1987 Dec; 206(6):685-93. PubMed ID: 2961314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N; Eid A; Stockman J; Gonen M; Schwartz L; Tetzlaff E; Paty P
    J Surg Oncol; 2005 Aug; 91(2):97-101. PubMed ID: 16028279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC; Rayner AA; Economou JS; Ignoffo RJ; Lewis BJ; Stagg RJ
    Cancer; 1986 Feb; 57(3):465-70. PubMed ID: 2935242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR.
    Kemeny MM; Battifora H; Blayney DW; Cecchi G; Goldberg DA; Leong LA; Margolin KA; Terz JJ
    Ann Surg; 1985 Aug; 202(2):176-81. PubMed ID: 3160313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer.
    Patt YZ; Boddie AW; Charnsangavej C; Ajani JA; Wallace S; Soski M; Claghorn L; Mavligit GM
    J Clin Oncol; 1986 Sep; 4(9):1356-64. PubMed ID: 2943876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
    Kemeny N; Daly J; Reichman B; Geller N; Botet J; Oderman P
    Ann Intern Med; 1987 Oct; 107(4):459-65. PubMed ID: 2957943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump.
    Balch CM; Urist MM; Soong SJ; McGregor M
    Ann Surg; 1983 Nov; 198(5):567-73. PubMed ID: 6227295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
    Kemeny N; Seiter K; Niedzwiecki D; Chapman D; Sigurdson E; Cohen A; Botet J; Oderman P; Murray P
    Cancer; 1992 Jan; 69(2):327-34. PubMed ID: 1303612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein.
    Daly JM; Kemeny N; Sigurdson E; Oderman P; Thom A
    Arch Surg; 1987 Nov; 122(11):1273-7. PubMed ID: 2960296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
    Barone RM; Byfield JE; Goldfarb PB; Frankel S; Ginn C; Greer S
    Cancer; 1982 Sep; 50(5):850-62. PubMed ID: 6212114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
    Cohen AM; Schaeffer N; Higgins J
    Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump.
    Weiss GR; Garnick MB; Osteen RT; Steele GD; Wilson RE; Schade D; Kaplan WD; Boxt LM; Kandarpa K; Mayer RJ
    J Clin Oncol; 1983 May; 1(5):337-44. PubMed ID: 6199474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.